|
Κυριακή 13 Δεκεμβρίου 2020
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Evaluation of Noise Exposure Secondary to Wind Noise in Cyclists. : Evaluation of Noise Exposure Secondary to Wind Noise in Cyclist...
-
Head and neck squamous cell carcinoma (HNC) is one of the most common malignancies encountered in India. This is mainly attributed to rampan...
-
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated with Pembrolizumab : The Journal of Clinical Endocrinology &Met...
-
Zusammenfassung Hintergrund Leiomyome des Ösophagus sind seltene Tumoren, jedoch die häufigsten gutartigen Tumoren des Ösophagus ausgehe...
-
Publication date: 13 January 2017 Source: Polymer, Volume 108 http://ift.tt/2hXHA0P http://ift.tt/2hFhWA9
-
Taste perception is significantly affected by other sensory modalities such as vision, smell, and somatosensation. Such taste sensation elic...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου